Sanofi gets rights to Principia's Btk inhibitor for MS

Principia Biopharma Inc. (South San Francisco, Calif.) will grant Sanofi (Euronext:SAN; NYSE:SNY) exclusive,

Read the full 131 word article

User Sign In